Studies: Patient monitoring can save $15 billion a year

Patient monitoring systems have proven to provide a better quality of care to patents, but how much are these technologies saving in both time and money?

According to statistics from peer-reviewed papers by researchers from Harvard School of Medicine and a new Frost & Sullivan report, both of which evaluated the use of the EarlySense, a contact-free continuous monitoring (CFCM) system, the savings per each patient was approximately $19,950.

EarlySense assisted clinicians in earlier detection of patient deterioration, reduced patients stays, and minimized ICU stays. Further findings included:

  • 301,809 less falls.
  • 1,293,469 pressure ulcer reductions.
  • 17,246,250 fewer med/surg days.
  • 2,701,913 less days in ICU.
  • 259,556 less code blue alerts.
  • 207,645 less deaths.

If these systems were to be put in all of the 750,000 hospital beds in the U.S., the estimated savings would amount to more than $15 billion a year, not including instances outside the hospital setting.

"More and more hospitals, as well as alternate care facilities, are taking advantage of the EarlySense technology to achieve improved economics and as a tool to help save lives. The powerful peer-reviewed data, as well as practical experience gained by clinicians using our technology on hundreds of thousands of patients, is why CFCM solutions are rapidly becoming standard of care in many institutions," said Avner Halperin, CEO of EarlySense. "We are excited to continue to offer the most advanced CFCM solutions to our customers in the U.S. and abroad, and to expand our reach to new facilities to help achieve positive patient outcomes and improved economics for the healthcare system."

""
Cara Livernois, News Writer

Cara joined TriMed Media in 2016 and is currently a Senior Writer for Clinical Innovation & Technology. Originating from Detroit, Michigan, she holds a Bachelors in Health Communications from Grand Valley State University.

Around the web

Compensation for heart specialists continues to climb. What does this say about cardiology as a whole? Could private equity's rising influence bring about change? We spoke to MedAxiom CEO Jerry Blackwell, MD, MBA, a veteran cardiologist himself, to learn more.

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”